Peelaerts, W. et al. 2020. Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits. Free Neuropathology. 1, (Nov. 2020), 33. DOI:https://doi.org/10.17879/freeneuropathology-2020-3049.